☆ 4.7 Article

Key role of the gut-microbiota-brain axis via the subdiaphragmatic vagus nerve in demyelination of the cuprizone-treated mouse brain

NEUROBIOLOGY OF DISEASE (2023)

Related references

Note: Only part of the references are listed.

Article Clinical Neurology

A role of gut-microbiota-brain axis via subdiaphragmatic vagus nerve in depression-like phenotypes in Chrna7 knock-out mice

Yong Yang et al.

Summary: This study suggests that Chrna7 knockout mice exhibit depression-like behaviors and reduced expression of synaptic proteins in the medial prefrontal cortex through the gut-microbiota-brain axis via the subdiaphragmatic vagus nerve. Subdiaphragmatic vagotomy can block these depression-like behaviors and alter the composition of gut microbiota and microbiota-derived metabolites.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2023)

Add to Collection

Review Neurosciences

Brain-spleen axis in health and diseases: A review and future perspective

Yan Wei et al.

Summary: The spleen, as an important tissue for the immune system, has been found to have a direct connection pathway with the brain and communicate through vagus nerve signaling. It affects various brain functions through immune modulation.

BRAIN RESEARCH BULLETIN (2022)

Add to Collection

Article Clinical Neurology

Microglial depletion and abnormalities in gut microbiota composition and short-chain fatty acids in mice after repeated administration of colony stimulating factor 1 receptor inhibitor PLX5622

Yong Yang et al.

Summary: Repeated administration of PLX5622, a CSF1R inhibitor, leads to a reduction in brain microglia as well as alteration in gut microbiota composition and lactic acid levels. The study suggests a potential crosstalk between microbiome and microglia through the brain-gut axis, highlighting the impact of manipulating brain microglia on gut microbiota.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2022)

Add to Collection

Article Neurosciences

Brain-gut-microbiota axis in depression: A historical overview and future directions

Lijia Chang et al.

Summary: This article reviews the latest findings on the brain-gut-microbiota axis in depression, which may play a key role in the pathophysiology of depression by regulating the neural and immune systems. Research suggests that the vagus nerve influences depression through this axis.

BRAIN RESEARCH BULLETIN (2022)

Add to Collection

Article Neurosciences

(R)-ketamine ameliorates demyelination and facilitates remyelination in cuprizone-treated mice: A role of gut-microbiota-brain axis

Xingming Wang et al.

Summary: The study suggests that (R)-ketamine could ameliorate demyelination in the brain of CPZ-treated mice through TrkB activation, and that gut-microbiota-microglia crosstalk may play a role in the demyelination of CPZ-treated mice. Therefore, (R)-ketamine could be a new therapeutic drug for MS.

NEUROBIOLOGY OF DISEASE (2022)

Add to Collection

Article Clinical Neurology

Gut-microbiota-brain axis in the vulnerability to psychosis in adulthood after repeated cannabis exposure during adolescence

Xiayun Wan et al.

Summary: Increasing epidemiological evidence suggests that cannabis use during adolescence may increase the risk for psychosis in adulthood. This study found that gut microbiota may play a role in the increased risk for psychosis in adults after exposure to cannabinoid receptor agonist WIN55,212-2 during adolescence.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2022)

Add to Collection

Article Neurosciences

Effects of (R)-ketamine on reduced bone mineral density in ovariectomized mice: A role of gut microbiota

Xiayun Wan et al.

Summary: Depression is associated with low bone mineral density (BMD) and a novel antidepressant (R)-ketamine can improve reduced BMD. This study found that gut microbiota plays a role in the beneficial effects of (R)-ketamine on reducing BMD. Therefore, (R)-ketamine could be a therapeutic drug for depressed patients or patients with osteoporosis.

NEUROPHARMACOLOGY (2022)

Add to Collection

Review Behavioral Sciences

(R)-ketamine as prophylactic and therapeutic drug for neurological disorders: Beyond depression

Xingming Wang et al.

Summary: Neurological disorders are a major cause of disability and death worldwide, driven by global population growth and aging. Depression is a common symptom in neurological disorders and a risk factor for AD, PD, and stroke. The antidepressant effects of (R,S)-ketamine were accidentally discovered, with (R)-ketamine showing greater potency and longer-lasting effects with lower side effects. Additionally, (R)-ketamine has beneficial effects in rodent models of PD, MS, and stroke. This article reviews the potential of (R)-ketamine as a prophylactic or therapeutic drug for neurological disorders including AD, PD, MS, and stroke.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2022)

Add to Collection

Review Behavioral Sciences

Brain stimulation and other biological non-pharmacological interventions in mental disorders: An umbrella review

Stella Rosson et al.

Summary: Biological non-pharmacological treatments are effective and safe for various mental disorders, although the certainty is limited. The results provide guidance for future research and guidelines.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Motor Behavioral Deficits in the Cuprizone Model: Validity of the Rotarod Test Paradigm

Concordia Lubrich et al.

Summary: In this review, the validity and characteristics of the rotarod test in cuprizone-intoxicated mice are provided. The rotarod test is a commonly used method to determine gait abnormalities.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Medicine, Research & Experimental

Annual Cost Burden by Level of Relapse Severity in Patients with Multiple Sclerosis

Jacqueline Nicholas et al.

Summary: This study revealed that the severity of relapses in multiple sclerosis is associated with direct healthcare costs, with total annual all-cause and MS-related costs increasing with the severity of relapses. High-efficacy treatments may reduce the severity of relapses, potentially lowering the cost of care for MS patients.

ADVANCES IN THERAPY (2021)

Add to Collection

Article Immunology

A role of the subdiaphragmatic vagus nerve in depression-like phenotypes in mice after fecal microbiota transplantation from Chrna7 knock-out mice with depression-like phenotypes

Yaoyu Pu et al.

Summary: The study suggests that FMT from Chrna7 KO mice can induce depression-like phenotypes in ABX-treated mice, primarily through affecting gut microbiota composition and neural pathways.

BRAIN BEHAVIOR AND IMMUNITY (2021)

Add to Collection

Article Neurosciences

(R)-ketamine ameliorates the progression of experimental autoimmune encephalomyelitis in mice

Xingming Wang et al.

Summary: The study found that (R)-ketamine effectively attenuated weight loss in EAE model mice and improved clinical scores. Additionally, it reduced pathological scores and preserved blood-brain barrier integrity in the spinal cord. These findings suggest that (R)-ketamine could be a promising prophylactic drug for MS.

BRAIN RESEARCH BULLETIN (2021)

Add to Collection

Editorial Material Cell Biology

Powering up microbiome-microglia interactions

Caoimhe M. K. Lynch et al.

Summary: Acetate is identified as an essential microbiota-derived molecule driving microglial metabolic pathways and functions during both healthy and diseased states in a methodological tour de force by Erny et al. (2021).

CELL METABOLISM (2021)

Add to Collection

Article Multidisciplinary Sciences

Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma

Jason Behary et al.

Summary: The study demonstrates that patients with NAFLD-HCC have dysbiosis in the gut microbiota, leading to modulation of peripheral immune responses and the induction of a T cell immunosuppressive phenotype.

NATURE COMMUNICATIONS (2021)

Add to Collection

Review Immunology

The second brain: The connection between gut microbiota composition and multiple sclerosis

Melina Farshbafnadi et al.

Summary: Patients with multiple sclerosis (MS) exhibit dysbiosis in their gut microbiota, including altered proportions of certain bacterial phyla compared to healthy individuals. Studies suggest that the composition of gut microbiota may affect the central nervous system and immune function, potentially playing a role in the pathogenesis of MS.

JOURNAL OF NEUROIMMUNOLOGY (2021)

Add to Collection

Article Immunology

RhANP attenuates endotoxin-derived cognitive dysfunction through subdiaphragmatic vagus nerve-mediated gut microbiota-brain axis

Yuming Wu et al.

Summary: The study found that atrial natriuretic peptide can mitigate neuroinflammation and cognitive impairment induced by bacterial lipopolysaccharide through the subdiaphragmatic vagus nerve-mediated gut microbiota-brain axis.

JOURNAL OF NEUROINFLAMMATION (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Gut Microbiota Changes in Experimental Autoimmune Encephalomyelitis and Cuprizone Mice Models

Laura Moles et al.

Summary: This study characterized microbial changes in murine demyelinating models and found correlations with disease progression, resembling characteristics of dysbiosis in multiple sclerosis (MS) patients. The findings provide insights into the interplay between microbiota and demyelination processes, highlighting the potential for modulating microbiota as a therapeutic strategy for MS.

ACS CHEMICAL NEUROSCIENCE (2021)

Add to Collection

Article Neurosciences

Reduction in CD11c+ microglia correlates with clinical progression in chronic experimental autoimmune demyelination

Florian Mayrhofer et al.

Summary: Multiple sclerosis (MS) is a chronic autoimmune demyelinating disease with diverse clinical symptoms and poorly understood mechanisms. Experimental autoimmune encephalomyelitis (EAE) mice with mild symptoms were found to progress clinically around 30 days post-EAE induction, with CD11c(+) microglia reduction and parenchymal infiltration playing a role. Sex-dependent differences mediated by p38 alpha signaling were observed, suggesting CD11c(+) microglia may regulate immune cell infiltration in autoimmune demyelination.

NEUROBIOLOGY OF DISEASE (2021)

Add to Collection

Review Economics

Economic Burden of Multiple Sclerosis in Low- and Middle-Income Countries: A Systematic Review

Jalal Dahham et al.

Summary: The study identified and reviewed the cost of illness of multiple sclerosis (MS) in low- and middle-income countries (LMICs), revealing variations in cost estimates mainly due to differences in the inclusion of costs of disease-modifying therapies, methodological choices, and perspectives adopted. Costs increased with disease severity, with similar cost ratios across different levels of MS severity. MS drug costs were the main driver for less severe MS, while direct non-medical costs and indirect costs increased with greater disease severity.

PHARMACOECONOMICS (2021)

Add to Collection

Article Multidisciplinary Sciences

Evaluation of changes in intestinal microbiota in Crohn's disease patients after anti-TNF alpha treatment

Laura Sanchis-Artero et al.

Summary: Intestinal dysbiosis plays a crucial role in the development of Crohn's disease (CD). A study conducted on CD patients undergoing anti-TNF treatment revealed significant changes in gut microbiota, with partial restoration observed in responders. The F.prausnitzii/E.coli ratio was identified as a reliable indicator of response to anti-TNF therapy in CD.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Clinical Neurology

Ingestion of Faecalibaculum rodentium causes depression-like phenotypes in resilient Ephx2 knock-out mice: A role of brain-gut-microbiota axis via the subdiaphragmatic vagus nerve

Siming Wang et al.

Summary: This study demonstrated that fecal microbiota transplantation from susceptible CSDS mice induced anhedonia-like behavior in antibiotic-treated WT and Ephx2 KO mice. Furthermore, it was suggested that Faecalibaculum rodentium might be responsible for the observed anhedonia-like behavior following FMT from susceptible CSDS mice.

JOURNAL OF AFFECTIVE DISORDERS (2021)

Add to Collection

Review Behavioral Sciences

Vagus nerve stimulation in brain diseases: Therapeutic applications and biological mechanisms

Yue Wang et al.

Summary: With the development of medical technology, vagus nerve stimulation (VNS) has been approved by the FDA as an alternative treatment for refractory epilepsy, refractory depression, cluster headaches, and migraines. Although VNS has shown promising results for more brain diseases like Parkinson's disease, autistic spectrum disorder, and traumatic brain injury, the specific biological mechanisms underlying its beneficial effects remain incompletely understood.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2021)

Add to Collection

Review Clinical Neurology

Depression in multiple sclerosis: Is one approach for its management enough?

C. Danielle Jones et al.

Summary: Depression is highly prevalent in patients with multiple sclerosis (MS) and can worsen symptoms. Current treatments, including medication, cognitive-behavior therapy, and exercise training, show moderate efficacy but lack a single gold-standard treatment. Combination therapies should be considered for managing depression in MS, although more research is needed to evaluate their effectiveness.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)

Add to Collection

Review Immunology

The Gut-Brain Axis in Multiple Sclerosis. Is Its Dysfunction a Pathological Trigger or a Consequence of the Disease?

Benedetta Parodi et al.

Summary: The gut-brain axis plays a crucial role in neurological diseases like multiple sclerosis (MS) and its murine model, experimental autoimmune encephalomyelitis (EAE), by modulating immune responses and disease progression through alterations in the gut microbiota. Dysbiosis-induced pro-inflammatory intestinal environment and altered communication with the central nervous system (CNS) may contribute to CNS inflammation in MS and EAE, while neuroinflammation affecting efferent cholinergic transmission could lead to intestinal inflammation as disease progresses.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Oligodendrocytes and Microglia: Key Players in Myelin Development, Damage and Repair

Ilias Kalafatakis et al.

Summary: This review summarizes the regulation of myelination by oligodendrocytes under physiological and pathological conditions, as well as the role of microglia in myelin generation, regeneration, and repair. The beneficial and detrimental roles of microglia in remyelination are discussed, along with the cellular and molecular components involved. Recent findings related to preclinical models using human stem cells for studying microglia in human pathologies and the impact of the microbiome on glial cell functions are also presented.

BIOMOLECULES (2021)

Add to Collection

Article Clinical Neurology

Gut microbiome alpha-diversity is not a marker of Parkinson's disease and multiple sclerosis

Jonathan Plassais et al.

Summary: The gut-brain axis may play a central role in neurological disorders. However, the alpha-diversity of gut microbiome does not seem to be significantly altered in patients with Parkinson's disease and multiple sclerosis compared to healthy controls. The Shannon diversity index is also not associated with neurological disorders.

BRAIN COMMUNICATIONS (2021)

Add to Collection

Review Medicine, Research & Experimental

Targeting the gut to treat multiple sclerosis

Laura Ghezzi et al.

Summary: The gut-brain axis refers to interactions between gut microbiota and nervous, immune, and endocrine systems, potentially playing a role in multiple sclerosis pathogenesis. Studies have shown that pwMS are more likely to exhibit altered microbiota and metabolites, with approaches such as antibiotics and fecal microbiota transplantation showing promising outcomes in preventing CNS inflammation. However, more research is needed to establish consistent results and large-scale randomized controlled trials are lacking in this area.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Add to Collection

Article Neurosciences

How microbiota shape microglial phenotypes and epigenetics

Daniel Erny et al.

GLIA (2020)

Add to Collection

Review Immunology

Microglia in Multiple Sclerosis: Friend or Foe?

Brooke L. Guerrero et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Review Cell Biology

The Cuprizone Model: Dos and Do Nots

Jiangshan Zhan et al.

CELLS (2020)

Add to Collection

Article Microbiology

Development of a Novel Metagenomic Biomarker for Prediction of Upper Gastrointestinal Tract Involvement in Patients With Crohn's Disease

Min Seob Kwak et al.

FRONTIERS IN MICROBIOLOGY (2020)

Add to Collection

Article Psychiatry

A key role of the subdiaphragmatic vagus nerve in the depression-like phenotype and abnormal composition of gut microbiota in mice after lipopolysaccharide administration

Jiancheng Zhang et al.

TRANSLATIONAL PSYCHIATRY (2020)

Add to Collection

Article Clinical Neurology

The microbiota-microglia axis in central nervous system disorders

Omar Mossad et al.

BRAIN PATHOLOGY (2020)

Add to Collection

Editorial Material Immunology

A One-Two Punch in the Gut May Trigger Multiple Sclerosis

Amir-Hadi Maghzi et al.

IMMUNITY (2020)

Add to Collection

Article Immunology

Ingestion ofLactobacillus intestinalisandLactobacillus reutericauses depression- and anhedonia-like phenotypes in antibiotic-treated mice via the vagus nerve

Siming Wang et al.

JOURNAL OF NEUROINFLAMMATION (2020)

Add to Collection

Article Immunology

A Metagenome-Wide Association Study of Gut Microbiome in Patients With Multiple Sclerosis Revealed Novel Disease Pathology

Toshihiro Kishikawa et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)

Add to Collection

Review Immunology

Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis

Qianquan Ma et al.

JOURNAL OF NEUROINFLAMMATION (2019)

Add to Collection

Review Physiology

THE MICROBIOTA-GUT-BRAIN AXIS

John F. Cryan et al.

PHYSIOLOGICAL REVIEWS (2019)

Add to Collection

Article Immunology

Butyrate suppresses demyelination and enhances remyelination

Tong Chen et al.

JOURNAL OF NEUROINFLAMMATION (2019)

Add to Collection

Review Immunology

Microbiome-microglia connections via the gut-brain axis

Reem Abdel-Haq et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2019)

Add to Collection

Review Biochemistry & Molecular Biology

Microglia in Central Nervous System Inflammation and Multiple Sclerosis Pathology

Sofie Voet et al.

TRENDS IN MOLECULAR MEDICINE (2019)

Add to Collection

Article Neurosciences

Gut bacteria interaction with vagal afferents

Carolina R. Cawthon et al.

BRAIN RESEARCH (2018)

Add to Collection

Review Immunology

The roles of macrophages and microglia in multiple sclerosis and experimental autoimmune encephalomyelitis

Fengna Chu et al.

JOURNAL OF NEUROIMMUNOLOGY (2018)

Add to Collection

Review Neurosciences

The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis

Bruno Bonaz et al.

FRONTIERS IN NEUROSCIENCE (2018)

Add to Collection

Review Immunology

The Gut-Microglia Connection: Implications for Central Nervous System Diseases

Yiliang Wang et al.

FRONTIERS IN IMMUNOLOGY (2018)

Add to Collection

Review Neurosciences

Regenerating CNS myelin - from mechanisms to experimental medicines

Robin J. M. Franklin et al.

NATURE REVIEWS NEUROSCIENCE (2017)

Add to Collection

Article Nutrition & Dietetics

Meta-Analysis of Fecal Microbiota and Metabolites in Experimental Colitic Mice during the Inflammatory and Healing Phases

Toshifumi Osaka et al.

NUTRIENTS (2017)

Add to Collection

Review Biochemistry & Molecular Biology

Hypothesis testing and statistical analysis of microbiome

Yinglin Xia et al.

GENES & DISEASES (2017)

Add to Collection

Review Clinical Neurology

Multiple sclerosis animal models: a clinical and histopathological perspective

Markus Kipp et al.

BRAIN PATHOLOGY (2017)

Add to Collection

Article Pharmacology & Pharmacy

Animal models of Multiple Sclerosis

Claudio Procaccini et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2015)

Add to Collection

Article Medicine, General & Internal

Gut Microbiota in Multiple Sclerosis: Possible Influence of Immunomodulators

Brandi L. Cantarel et al.

JOURNAL OF INVESTIGATIVE MEDICINE (2015)

Add to Collection

Article Biochemical Research Methods

MS-DIAL: data-independent MS/MS deconvolution for comprehensive metabolome analysis

Hiroshi Tsugawa et al.

NATURE METHODS (2015)

Add to Collection

Editorial Material Engineering, Environmental

Identifying Small Molecules via High Resolution Mass Spectrometry: Communicating Confidence

Emma L. Schymanski et al.

ENVIRONMENTAL SCIENCE & TECHNOLOGY (2014)

Add to Collection

Review Immunology

The Benefits and Detriments of Macrophages/Microglia in Models of Multiple Sclerosis

Khalil S. Rawji et al.

CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)

Add to Collection

Article Neurosciences

Myelin debris regulates inflammatory responses in an experimental demyelination animal model and multiple sclerosis lesions

Tim Clarner et al.

GLIA (2012)

Add to Collection

Article Multidisciplinary Sciences

Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve

Javier A. Bravo et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Add to Collection

Article Biotechnology & Applied Microbiology

Metagenomic biomarker discovery and explanation

Nicola Segata et al.

GENOME BIOLOGY (2011)

Add to Collection

Review Neurosciences

Animal Models of MS RevealMultiple Roles of Microglia in Disease Pathogenesis

Zhen Gao et al.

NEUROLOGY RESEARCH INTERNATIONAL (2011)

Add to Collection

Article Clinical Neurology

The cuprizone model for demyelination

O. Torkildsen et al.

ACTA NEUROLOGICA SCANDINAVICA (2008)

Add to Collection

Article Clinical Neurology

Vagal nerve stimulation improves cerebellar tremor and dysphagia in multiple sclerosis

F. Marrosu et al.

MULTIPLE SCLEROSIS (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.